SCYNEXIS CLO awarded 129,833 restricted stock units

SCYNEXIS Inc. granted equity compensation to its Chief Legal Officer, Scott Sukenick.

Rhea-AI Filing Summary

SCYNEXIS Inc. granted equity compensation to its Chief Legal Officer, Scott Sukenick. On January 29, 2026, he received 129,833 shares of common stock at a price of $0 per share in the form of restricted stock units. These units vest one third per year over three years starting February 28, 2026, providing time-based retention incentives. Following this grant, he beneficially owns 574,539 shares of SCYNEXIS common stock in direct ownership.

Insider Trade Summary

Grant/Award: 129,833 shares

Grant/Award 1 txn

Insider Sukenick Scott

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	129,833	$0.00	$0.00

Holdings After Transaction: Common Stock — 574,539 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units that vest one third per year over three years as measured from February 28, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SCYNEXIS (SCYX) report for its Chief Legal Officer?

SCYNEXIS reported an equity grant to Chief Legal Officer Scott Sukenick. He received 129,833 shares of common stock as restricted stock units, priced at $0 per share, as part of his compensation, increasing his directly held beneficial ownership to 574,539 shares.

When did the SCYNEXIS (SCYX) restricted stock unit grant to Scott Sukenick occur?

The restricted stock unit grant to Chief Legal Officer Scott Sukenick occurred on January 29, 2026. This date reflects when the 129,833 common stock units were awarded, as disclosed in the insider ownership report filed under Section 16 of the Securities Exchange Act.

How many SCYNEXIS (SCYX) shares did the Chief Legal Officer receive and at what price?

Chief Legal Officer Scott Sukenick received 129,833 shares of SCYNEXIS common stock. These were granted as restricted stock units at a transaction price of $0 per share, indicating they are a compensation award rather than an open-market purchase or sale.

What is the vesting schedule for Scott Sukenick’s SCYNEXIS (SCYX) restricted stock units?

The 129,833 restricted stock units vest over three years. One third of the award vests each year, measured from February 28, 2026, creating a staggered vesting schedule that ties continued service to the realization of the full equity grant.

How many SCYNEXIS (SCYX) shares does Scott Sukenick beneficially own after this transaction?

After the January 29, 2026 grant, Scott Sukenick beneficially owns 574,539 shares of SCYNEXIS common stock. This total reflects his direct ownership position following the addition of 129,833 restricted stock units awarded as part of his compensation package.

Is the SCYNEXIS (SCYX) Chief Legal Officer’s equity held directly or through another entity?

The filing shows the Chief Legal Officer’s 574,539 SCYNEXIS shares as directly owned. The transaction is reported with ownership form marked "D" for direct, and there is no footnote indicating indirect ownership through a trust, partnership, or other affiliated entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sukenick Scott

(Last) (First) (Middle)

1 EVERTRUST PLAZA

13TH FLOOR

(Street)

JERSEY CITY NJ 07302

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SCYNEXIS INC [ SCYX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/29/2026		A		129,833(1)	A	$0	574,539	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units that vest one third per year over three years as measured from February 28, 2026.

	/s/ Robert F. Joyce Jr., by Power of Attorney	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.